The Fen-Phen legal case and its consequences
- Fen-Phen, a combination of the diet drugs fenfluramine and dexfenfluramine, was found to cause serious health problems, including pulmonary hypertension.
- Individuals who took Fen-Phen and suffered from pulmonary hypertension pursued personal injury claims against the manufacturers of the drugs, American Home Products Corporation (AHPC) .
- The Fen-Phen legal case resulted in a settlement of $3.75 billion to thousands of people who claimed they were injured by taking the drugs
- . However, this settlement did not cover the 100 claims from people who contended that fen-phen gave them primary pulmonary hypertension.
- The Fen-Phen legal case highlighted the importance of rigorous testing and regulation of drugs before they are marketed to the public
Action Plan
Who is who in this project?
References and Bibliography
Aminorex to Fen/Phen: An Epidemic Foretold
Lawsuits Over Fen-Phen Side Effects Years Later Allowed to Proceed
Fen-Phen Lawsuit Settlements May Still Be Available
2023 Fen-Phen – Pulmonary Hypertension
[1] https://www.westinjurylawyers.com/fen-phen-settlements-expected-lawsuits-involving-primary-pulmonary-hypertension-pph/
[2] https://www.schmidtlaw.com/fen-phen-primary-pulmonary-hypertension-pph/
[3] https://www.aboutlawsuits.com/pfizer-fen-phen-objection-dismissed-32760/
[4] https://beckerlaw.com/kentucky-mass-torts-lawyer/prescription-drugs/fen-phen/side-effects/
[5] https://www.lieffcabraser.com/injury/drugs/fen-phen/
[6] https://ckglawfirm.com/fen-phen-pph-pah
